Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AK”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Large-scale testing (Phase 3)Looking for participantsNCT07137819
What this trial is testing

Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis

Who this might be right for
Actinic Keratosis of Face and Scalp
Aresus Pharma GmbH 280
Testing effectiveness (Phase 2)Study completedNCT03110159
What this trial is testing

DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

Who this might be right for
Skin CancerNon-melanoma Skin CancerSun Damaged Skin+1 more
Medical Dermatology Specialists 8
Large-scale testing (Phase 3)Study completedNCT03285477
What this trial is testing

A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp

Who this might be right for
Actinic Keratoses
Almirall, S.A. 351
Large-scale testing (Phase 3)Active Not RecruitingNCT05662202
What this trial is testing

Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp

Who this might be right for
Actinic Keratoses
Biofrontera Inc. 172
Testing effectiveness (Phase 2)UnknownNCT00829192
What this trial is testing

Phase II AK Study in Organ Transplant Patients

Who this might be right for
Actinic KeratosesCarcinoma, Squamous CellOrgan Transplant Recipients
Clinuvel Pharmaceuticals Limited 200
Not applicableStudy completedNCT05260073
What this trial is testing

Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis

Who this might be right for
Keratosis, Actinic
Almirall, S.A. 300
Early research (Phase 1)Study completedNCT01836367
What this trial is testing

Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp

Who this might be right for
Actinic Keratosis
Icahn School of Medicine at Mount Sinai 20
Not applicableStudy completedNCT03202485
What this trial is testing

Comparison Between TICL and ICL+AK for High Myopic Astigmatism

Who this might be right for
AstigmatismHigh Myopia
Wenzhou Medical University 62
Post-approval studies (Phase 4)Study completedNCT00115154
What this trial is testing

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands

Who this might be right for
Keratosis
Graceway Pharmaceuticals, LLC 270
Not applicableStudy completedNCT01202708
What this trial is testing

Gambro AK200 ULTRA Hemodiafiltration Study

Who this might be right for
Chronic Renal Failure
Vantive Health LLC 14
Early research (Phase 1)Looking for participantsNCT07318675
What this trial is testing

A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.

Who this might be right for
Actinic Keratosis (AK)
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. 40
Large-scale testing (Phase 3)Study completedNCT03116698
What this trial is testing

Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period

Who this might be right for
Actinic Keratosis (AK)
Dr. Reddy's Laboratories Limited 240
Testing effectiveness (Phase 2)Study completedNCT00991861
What this trial is testing

Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis

Who this might be right for
Actinic Keratosis
Almirall, S.A. 100
Not applicableStudy completedNCT05522036
What this trial is testing

Clinical Evaluation of a Short Illumination Duration (35 Minutes) When Performing PDT of AK Using the Dermaris ®

Who this might be right for
Actinic Keratoses
Centre Dermatologique du Roy 25
Early research (Phase 1)Study completedNCT02411851
What this trial is testing

Treatment of Actinic Keratoses (AK) on the Face

Who this might be right for
Actinic Keratoses
Icahn School of Medicine at Mount Sinai 20
Not applicableStudy completedNCT07290959
What this trial is testing

Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK

Who this might be right for
Actinic Keratosis (AK)
San Salvatore Hospital of L'Aquila 55
Early research (Phase 1)UnknownNCT03321318
What this trial is testing

AK-R215 Pharmacokinetic Study Phase I

Who this might be right for
Healthy
Alvogen Korea 52
Post-approval studies (Phase 4)Study completedNCT02736760
What this trial is testing

Daylight-PDT With MAL for AK and Photodamaged Skin

Who this might be right for
Actinic KeratosesPhotodamaged Skin
University Hospital Regensburg 58
Not applicableWithdrawnNCT00814528
What this trial is testing

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

Who this might be right for
Actinic Keratosis
University of Chicago
Large-scale testing (Phase 3)Study completedNCT01265602
What this trial is testing

Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis

Who this might be right for
Actinic Keratosis
Almirall, S.A. 889
Load More Results